edelfosine has been researched along with squalene in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Blanco-Prieto, MJ; Couvreur, P; Desmaële, D; Irusta, S; Rodríguez-Nogales, C; Sebastián, V | 1 |
Blanco-Prieto, MJ; Couvreur, P; Mura, S; Rodríguez-Nogales, C | 1 |
2 other study(ies) available for edelfosine and squalene
Article | Year |
---|---|
A unique multidrug nanomedicine made of squalenoyl-gemcitabine and alkyl-lysophospholipid edelfosine.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Deoxycytidine; Gemcitabine; Humans; Lysophospholipids; Microscopy, Electron, Transmission; Nanomedicine; Particle Size; Phospholipid Ethers; Prodrugs; Squalene | 2019 |
Squalenoyl-gemcitabine/edelfosine nanoassemblies: Anticancer activity in pediatric cancer cells and pharmacokinetic profile in mice.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Drug Compounding; Drug Synergism; Female; Inhibitory Concentration 50; Injections, Intravenous; Mice, Nude; Nanoconjugates; Nanoparticles; Neuroblastoma; Osteosarcoma; Phospholipid Ethers; Squalene | 2020 |